Sanofi-Aventis Invests $65M in Cambridge, Massachusetts Growth
07/08/2010
"We believe that Cambridge is really the heart of oncology today,'' Hanspeter Spek, president of Sanofi-Aventis global operations, said in a company conference call this year. "We intend to benefit from this environment as a neighbor.''
Massachusetts is banking on the pharmaceutical industry to buoy the state's economy. Two years ago Governor Deval Patrick began a $1 billion, 10-year plan to offer tax incentives to life sciences companies. Last year, 26 companies received a total of $24.5 million.
Sanofi-Aventis has applied for $2.45 million in state tax credits from the Life Sciences Center, and will ask for another $6.5 million over the next four years.
Several other foreign pharmaceutical companies have facilities around Boston, such as Novartis, Merck, GlaxoSmithKline, and AstraZeneca.
Project Announcements
DDP Specialty Electronic Materials US Expands Midland, Michigan, Manufacturing Operations
01/30/2026
Aerospace Lubricants Expands Columbus, Ohio, Production Operations
01/30/2026
Radical AI Plans Brooklyn, New York, Materials Science Operations
01/28/2026
Germany-Based KettenWulf Plans Auburn, Alabama, Production Operations
01/28/2026
Frontieras North America Plans Mason County, West Virginia, Operations
01/28/2026
North Wind Plans Rosemount, Minnesota, Research Operations
01/27/2026
Most Read
-
The Workforce Bottleneck in America’s Manufacturing Revival
Q4 2025
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Tariff Shockwaves Hit the Industrial Sector
Q4 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Investors Seek Shelter in Food-Focused Real Estate
Q3 2025